Standardization of in vitro testing for cardiovascular implants in the era of European Medical Device Regulation
In case of cardiovascular implants classified as class III medical products there is a specific responsibility for manufacturers as well as regulatory authorities to follow international standards to guarantee for safety and efficacy. Fast developments of science and technology as well as novel clin...
Guardado en:
Autores principales: | Schmidt Wolfram, Brandt-Wunderlich Christoph, Stiehm Michael, Kaule Sebastian, Siewert Stefan, Bock Andrea, Schmitz Klaus-Peter, Kurzhals Anja, Grabow Niels |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d9823466539044679c00eb19724397cc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Standardization of in vitro testing for cardiovascular implants in the era of European Medical Device Regulation
por: Schmidt Wolfram, et al.
Publicado: (2020) -
Transcatheter mitral valve repair devices - in vitro studies on the influence of device-width on mitral regurgitation
por: Ott Robert, et al.
Publicado: (2020) -
Transfer activities for cardiovascular, ophthalmologic and otolaryngologic medical device innovations
por: Grabow Niels, et al.
Publicado: (2020) -
Medical Device Regulation and current challenges for the implementation of new technologies
por: Kaule Sebastian, et al.
Publicado: (2020) -
Impact of aortic annulus geometry according to ISO 5840:2019 (draft) on hydrodynamic performance of transcatheter aortic valve prostheses
por: Oldenburg Jan, et al.
Publicado: (2020)